Gland Pharma on Friday said its board has appointed Shyamakant Giri as chief executive officer with effect from Jan. 15, 2025. Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals, responsible for the commercial expansion and growth in India and Rest of the World markets.
ADVERTISEMENT
Srinivas Sadu will continue to be the executive chairman of the company and support its next phase of growth, Gland Pharma said.
ADVERTISEMENT
RECOMMENDED FOR YOU
Gland Pharma Q2 Review - Beat Due To Controlled Costs; Base Business Yet To Witness Revival: Motilal Oswal
Nov 05, 2024
Gland Pharma Q2 Results: Profit Falls 16%, Meets Estimates
Nov 04, 2024
 11_07_24 (1).jpg?rect=0%2C0%2C3500%2C1969&w=75)
Festive Effect: GST Mop-Up Grows 9% To Rs 1.87 Lakh Crore In October
Nov 01, 2024
Credit Card Rules, UPI Lite, Train Ticket Booking: Check Major Changes Coming To Effect From Nov. 1
Oct 31, 2024
POPULAR
1
IPL 2025 Auction: Pant And Shreyas Iyer Become Costliest Players In IPL History; Warner Goes Unsold
2
IPL Auction 2025: Pant And Iyer Set Record As Most Expensive IPL Auction Buys
3
Your Guide To FII Positions For Nov. 25 Trade
4
Maharashtra Election Results 2024: Winners With Highest Victory Margins — Kashiram Pawara To Eknath Shinde
5